Meet Zhong Zhong and Hua Hua, two cloned macaque monkeys. Chinese scientists first unveiled these monkeys several weeks ago, marking the first time primates have been successfully cloned with the same method that created Dolly the sheep in 1996. Just as it did then, the science research community instantly raised ethical questions and concerns about human cloning. Theoretically, human cloning could be achieved in two ways. Reproductive human cloning would entail creating a living human, identical to another person previously or currently alive.
By SNEHA KABARIA
A team of Cornell chemical engineers in partnership with New England Biolabs have developed a method to efficiently produce antibodies in the cytoplasm in E. coli bacteria, leading to a new drug development platform. The research was led by co-senior author Prof. Matthew DeLisa, chemical engineering, and first author Michael-Paul Robinson ’16 grad. Robinson is part of the Cornell Sloan and Colman Fellowship Program, which supplied funding for the project. The research, which has been ongoing for approximately five years, was published in a paper entitled “Efficient expression of full-length antibodies in the cytoplasm of engineered bacteria” in Nature Communications on Aug. 17.
In an effort to help alleviate the economic strain on customers, Wegmans Food Market Inc. has decided to make prescriptions for oral antibiotics free for its Club Shoppers. The program will run during the months when usage of such medicine peaks, from Jan. 7 to March 31.
“We realize that customers and employers are feeling the pinch of economy,” Jeanne Colleluori, Wegmans communications and media specialist. “One way to help people lead healthier lives is by relieving the economic pressure of their pharmaceutical requirements.”
Although Wegmans will not divulge the financial cost of this initiative, the company expects that its customers will save $1 million.